Zobrazeno 1 - 10
of 215
pro vyhledávání: '"J Blondon"'
Autor:
Laurence Moureau-Zabotto, J Blondon, J.P Lefranc, Delphine Lerouge, E. Touboul, Catherine Genestie
Publikováno v:
Cancer/Radiothérapie. 8:155-167
Resume Objectif de l'etude. – Evaluer les resultats reactualises en termes de survie et de controle locoregional d'une etude concernant des cancers du sein localement evolues non inflammatoires traites par l’association d’une chimiotherapie pre
Autor:
J Blondon, J.P Lefranc, M. Jamali, M. Uzan, A. Bernard, J.M. Antoine, J. Milliez, P.E. Lhuillier, Serge Uzan, D. Atlan, E. Touboul, Catherine Genestie, M. Antoine, E. Deniaud-Alexandre, D. Jannet, V. Ganansia
Publikováno v:
Cancer/Radiothérapie. 6:217-237
Resume Objectif de l’etude. – Identifier des facteurs pronostiques et de risque de complications post-therapeutiques dans une serie de cancers du col uterin de stades I et II operables. Patientes et methodes. – De mai 1972 a janvier 1994, 414 c
Autor:
E. Deniaud-Alexandre, A. Bernard, E. Touboul, Catherine Genestie, J.P Lefranc, Serge Uzan, J Blondon
Publikováno v:
Cancer/Radiothérapie. 6:85-98
Resume Objectif. – Identifier des facteurs pronostiques et la toxicite dans une serie de cancers du col uterin de stades IB et II operables et de gros volume traites par irradiation premiere et chirurgie. Patientes et methodes. – De juillet 1982
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 8(3)
To evaluate our updated data concerning survival and locoregional control in a study of locally advanced non inflammatory breast cancer after primary chemotherapy followed by external preoperative irradiation.Between 1982 and 1998, 120 patients (75 s
Autor:
D, Atlan, E, Touboul, E, Deniaud-Alexandre, J P, Lefranc, V, Ganansia, A, Bernard, J M, Antoine, D, Jannet, P E, Lhuillier, M, Uzan, C, Genestie, M, Antoine, M, Jamali, J, Milliez, S, Uzan, J, Blondon
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 6(4)
To identify prognostic factors and treatment toxicity in a series of operable stages IB and II cervical carcinomas.Between May 1972 and January 1994, 414 patients (pts) with cervical carcinoma staged according to the 1995 FIGO staging system underwen
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 6(2)
To identify prognostic factors and treatment toxicity in a series of operable bulky stages I and II cervical carcinomas treated with a therapeutic modality combining primary irradiation and surgery.Between July 1982 and May 1996, 66 patients with bul
Autor:
E, Touboul, Y, Belkacémi, L, Buffat, E, Deniaud-Alexandre, J P, Lefranc, P, Lhuillier, S, Uzan, D, Jannet, M, Uzan, M, Antoine, C, Ginesty, V, Ganansia, M, Jamali, J, Milliez, J, Blondon, M, Schlienger
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 5(4)
To identify prognostic factors and treatment toxicity in a series of operable endometrial adenocarcinomas.Between November 1971 and October 1992, 437 patients (pts) with endometrial carcinoma, staged according to the 1988 FIGO staging system, underwe
Autor:
J J, Baldauf, R, Barrasso, D, Benmoura, B, Huynh, J L, Mergui, T, Beuret, B, Blanc, J, Blondon
Publikováno v:
Gynecologie, obstetriquefertilite. 28(9)
Publikováno v:
Contraception, fertilite, sexualite (1992). 26(9)
Fifty-two women with stage Ib2 and II bulky squamous cell carcinoma of the uterine cervix (mean size: 5.65 +/- 0.12 cm, range: 5-8 cm) were treated between July 1982 and December 1993. The median follow-up was 73 months. Their patient's age ranged fr
Publikováno v:
Bulletin de l'Academie nationale de medecine. 181(7)
Epidemiology and natural history of cervical and endometrial carcinomas are not identical. So, the part of surgery in their prevention is different. For cervical carcinoma, mass screening and prevention allowed reduction of rates of incidence and mor